Prospection Website
  • Home
  • About Us
  • Products & Services
  • Articles
  • Careers
  • Contact
  • English
    • 日本語
    • 中文 (简体)
  • Request Demo

A retrospective review of the persistence of bDMARDs prescribed for the treatment of rheumatoid arthritis in the Australian population.

Kristina Turner

Authors: Graeme Jones, Stephen Hall, Paul Bird, Geoff Littlejohn, Kathleen Tymms, Peter Youssef, Eric Chung, Rina Barrett, Peter Button
International Journal of Rheumatic Diseases 2018; 21: 1581–1590

Download

bDMARDrheumatoid arthritis

Related Articles

Article

Predictive Health Technology for Global Markets

Adam Hawkins, Director International Markets

22.04.2021
Article

Data helping Rare Cancers

An estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths occurred Worldwide in 2020 (GLOBOCAN 2020). In Australia, cancer is the leading cause of health burden. More than 1 million people in…

12.03.2021
Article

Real World Evidence for Rare disease

Rare disease Day, recognises the 6,000+ identified, often life threatening, rare diseases*. Affecting over 300,000 million people worldwide, 72% of rare diseases are genetic, with 70% of those starting in childhood*. The low prevalence and…

28.02.2021
Prospection Website

Prospection is a healthcare data analytics company delivering real world and commercial insights through proprietary SaaS analytics platforms

© 2021 Prospection Pty Ltd - Privacy Policy

Contact Us

Level 6 Sydney Central
477 Pitt Street Haymarket NSW 2000 Australia
T
+61 2 9209 4035
E
contact@prospection.com
Prospection Website

Stay Updated

Register here to stay informed about Prospection
  • This field is for validation purposes and should be left unchanged.